Klaus Mayer

675 total citations
31 papers, 438 citations indexed

About

Klaus Mayer is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Klaus Mayer has authored 31 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Klaus Mayer's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (4 papers) and Blood groups and transfusion (4 papers). Klaus Mayer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (4 papers) and Blood groups and transfusion (4 papers). Klaus Mayer collaborates with scholars based in Germany, United States and Switzerland. Klaus Mayer's co-authors include Ulrich Brinkmann, Yuman Fong, Murray F. Brennan, Martin S. Karpeh, Marjorie B. Zucker, Jennie Borrelli, Allyn B. Ley, Raffael Schaffrath, David A. Scheinberg and William D. Hardy and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Blood.

In The Last Decade

Klaus Mayer

29 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Mayer Germany 13 154 104 95 76 72 31 438
Mohammad Mahdi Kooshyar Iran 10 188 1.2× 164 1.6× 100 1.1× 7 0.1× 38 0.5× 28 490
Takehiro Matsuda Japan 11 120 0.8× 201 1.9× 84 0.9× 5 0.1× 49 0.7× 25 473
M. Haq United Kingdom 8 150 1.0× 51 0.5× 60 0.6× 12 0.2× 80 1.1× 11 405
日本癌学会 4 83 0.5× 67 0.6× 83 0.9× 23 0.3× 7 0.1× 7 374
M. A. Nikolaeva Russia 11 114 0.7× 150 1.4× 27 0.3× 13 0.2× 12 0.2× 38 430
Kayoko Matsumoto Japan 11 114 0.7× 59 0.6× 38 0.4× 8 0.1× 134 1.9× 27 334
Suping Han China 17 389 2.5× 175 1.7× 123 1.3× 10 0.1× 9 0.1× 30 709
Xin Yin China 8 99 0.6× 29 0.3× 64 0.7× 18 0.2× 14 0.2× 41 312
Y. Yamashita Japan 10 108 0.7× 66 0.6× 122 1.3× 22 0.3× 11 0.2× 28 386
Guangming Cao China 13 225 1.5× 139 1.3× 52 0.5× 12 0.2× 6 0.1× 34 506

Countries citing papers authored by Klaus Mayer

Since Specialization
Citations

This map shows the geographic impact of Klaus Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Mayer more than expected).

Fields of papers citing papers by Klaus Mayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Mayer. The network helps show where Klaus Mayer may publish in the future.

Co-authorship network of co-authors of Klaus Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Mayer. A scholar is included among the top collaborators of Klaus Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Mayer. Klaus Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayer, Klaus, et al.. (2025). Diphthamide synthesis is linked to the eEF2‐client chaperone machinery. FEBS Letters. 599(9). 1260–1268. 1 indexed citations
3.
Mayer, Klaus, et al.. (2023). DPH1 and DPH2 variants that confer susceptibility to diphthamide deficiency syndrome in human cells and yeast models. Disease Models & Mechanisms. 16(9). 3 indexed citations
4.
Dickopf, Steffen, et al.. (2023). Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapy. mAbs. 15(1). 2245111–2245111. 5 indexed citations
5.
Mayer, Klaus, et al.. (2023). DPH1 Gene Mutations Identify a Candidate SAM Pocket in Radical Enzyme Dph1•Dph2 for Diphthamide Synthesis on EF2. Biomolecules. 13(11). 1655–1655. 2 indexed citations
6.
Zhang, Hongliang, Julia Quintana, Lorenz Adrian, et al.. (2022). Translational fidelity and growth of Arabidopsis require stress-sensitive diphthamide biosynthesis. Nature Communications. 13(1). 4009–4009. 13 indexed citations
7.
Mendelsohn, Bryce A., Klaus Mayer, Amit Malhotra, et al.. (2020). Diphthamide-deficiency syndrome: a novel human developmental disorder and ribosomopathy. European Journal of Human Genetics. 28(11). 1497–1508. 21 indexed citations
8.
Dengl, Stefan, Klaus Mayer, Felix Bormann, et al.. (2020). Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices. Nature Communications. 11(1). 4974–4974. 29 indexed citations
9.
Urreizti, Roser, Klaus Mayer, Gilad D. Evrony, et al.. (2019). DPH1 syndrome: two novel variants and structural and functional analyses of seven missense variants identified in syndromic patients. European Journal of Human Genetics. 28(1). 64–75. 12 indexed citations
10.
Mayer, Klaus, et al.. (2018). Importance of diphthamide modified EF2 for translational accuracy and competitive cell growth in yeast. PLoS ONE. 13(10). e0205870–e0205870. 21 indexed citations
11.
Mayer, Klaus, Olaf Mundigl, Hubert Kettenberger, et al.. (2018). Diphthamide affects selenoprotein expression: Diphthamide deficiency reduces selenocysteine incorporation, decreases selenite sensitivity and pre-disposes to oxidative stress. Redox Biology. 20. 146–156. 19 indexed citations
13.
Mayer, Klaus, et al.. (2017). Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADPRibosylating Toxins. Toxins. 9(3). 78–78. 10 indexed citations
14.
Haas, Alexander K., Klaus Mayer, & Ulrich Brinkmann. (2012). Generation of Fluorescent IgG Fusion Proteins in Mammalian Cells. Methods in molecular biology. 901. 265–276. 2 indexed citations
15.
Aust, Sylvia, Walter Jaeger, M. Klimpfinger, et al.. (2005). Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1. Journal of Pineal Research. 39(3). 276–282. 12 indexed citations
16.
Mayer, Klaus, Thomas Reinhard, Alexander Reis, et al.. (2003). Differential contribution of natural killer cells to corneal graft rejection in 3-week-old versus mature rats1. Transplantation. 76(3). 578–582. 10 indexed citations
17.
Fong, Yuman, Martin S. Karpeh, Klaus Mayer, & Murray F. Brennan. (1994). Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. The American Journal of Surgery. 167(2). 256–260. 77 indexed citations
18.
Mayer, Klaus, et al.. (1983). A computer system designed for a hospital transfusion service. Transfusion. 23(4). 316–321. 5 indexed citations
19.
Mayer, Klaus, et al.. (1968). Test in Vivo to Determine Donor Blood Compatibility. Transfusion. 8(1). 28–32. 5 indexed citations
20.
Mayer, Klaus & J. D’Amaro. (1968). Satisfactory Red Cell Viability with Slight Excess of Acid Citrate Dextrose. Blood. 32(3). 469–472. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026